Unknown

Dataset Information

0

A myosin-Va tail fragment sequesters dynein light chains leading to apoptosis in melanoma cells.


ABSTRACT: Previous studies proposed that myosin-Va regulates apoptosis by sequestering pro-apoptotic Bmf to the actin cytoskeleton through dynein light chain-2 (DLC2). Adhesion loss or other cytoskeletal perturbations would unleash Bmf, allowing it to bind and inhibit pro-survival Bcl2 proteins. Here, we demonstrated that overexpression of a myosin-Va medial tail fragment (MVaf) harboring the binding site for DLC2 dramatically decreased melanoma cell viability. Morphological and molecular changes, including surface blebbing, mitochondrial outer membrane permeabilization, cytochrome-c and Smac release, as well as caspase-9/-3 activation and DNA fragmentation indicated that melanoma cells died of apoptosis. Immobilized MVaf interacted directly with DLCs, but complexed MVaf/DLCs did not interact with Bmf. Overexpression of DLC2 attenuated MVaf-induced apoptosis. Thus, we suggest that, MVaf induces apoptosis by sequestering DLC2 and DLC1, thereby unleashing the pair of sensitizer and activator BH3-only proteins Bmf and Bim. Murine embryonic fibroblasts (MEFs) lacking Bim and Bmf or Bax and Bak were less sensitive to apoptosis caused by MVaf expression than wild-type MEFs, strengthening the putative role of the intrinsic apoptotic pathway in this response. Finally, MVaf expression attenuated B16-F10 solid tumor growth in mice, suggesting that this peptide may be useful as an apoptosis-inducing tool for basic and translational studies.

SUBMITTER: Izidoro-Toledo TC 

PROVIDER: S-EPMC3613824 | biostudies-other | 2013 Mar

REPOSITORIES: biostudies-other

altmetric image

Publications


Previous studies proposed that myosin-Va regulates apoptosis by sequestering pro-apoptotic Bmf to the actin cytoskeleton through dynein light chain-2 (DLC2). Adhesion loss or other cytoskeletal perturbations would unleash Bmf, allowing it to bind and inhibit pro-survival Bcl2 proteins. Here, we demonstrated that overexpression of a myosin-Va medial tail fragment (MVaf) harboring the binding site for DLC2 dramatically decreased melanoma cell viability. Morphological and molecular changes, includi  ...[more]

Similar Datasets

| S-EPMC7994366 | biostudies-literature
| S-EPMC18803 | biostudies-literature
| S-EPMC4914028 | biostudies-literature
| S-EPMC4242835 | biostudies-literature
| S-EPMC1937013 | biostudies-literature
| S-EPMC3038645 | biostudies-literature
| S-EPMC3689245 | biostudies-literature
| S-EPMC2234105 | biostudies-literature
| S-EPMC4148251 | biostudies-literature
| S-EPMC3410491 | biostudies-literature